Stryker is investing €200m in research and development at three of its five Cork facilities.
The medical technology company is developing new stroke treatment products at its neurovascular centre, developing manufacturing products for its spine, craniomaxillofacial, and joint replacement divisions, and designing new surgical devices in its Instruments Innovation Centre.
The research projects are supported by the Irish government, through IDA Ireland.
Minister for Innovation, Heather Humphreys, said the investment reflects Stryker’s commitment to Cork and Ireland.
“It is also a testament to our talented workforce. These RD&I projects are truly world-leading, highly innovative, and pioneering. Without a doubt, they have the potential to change the face of healthcare provision, reaffirming Ireland’s position as a global leader in the MedTech industry.“
IDA Ireland executive director, Mary Buckley, said Stryker has always been at the cutting edge of innovation, constantly developing new technologies in the fast and ever-changing medical technologies sector.
“Stryker is a major and valued employer in Cork, Limerick, and the wider south region.
“This projects further embeds Stryker, offering exciting and challenging opportunities to best-in-class researchers, and it positions Cork at the forefront of MedTech innovation.”